Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
13F holders, Q1 2024
Institutional positions in Psyence Biomedical Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +30 vs. Q4 2023
- Shares held
- 6.76M
- +6.76M vs. Q4 2023
- Total value
- $499.9K
- +$499.9K vs. Q4 2023
- New holders
- 30
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBMWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $121.6K |
| Q1 2026 | 19 | $96.6K |
| Q4 2025 | 21 | $101.1K |
| Q3 2025 | 23 | $142.4K |
| Q2 2025 | 23 | $123.8K |
| Q1 2025 | 23 | $96.4K |
| Q4 2024 | 22 | $80.2K |
| Q3 2024 | 23 | $79.2K |
| Q2 2024 | 28 | $71.9K |
| Q1 2024 | 30 | $499.9K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 73 | $5 | 0.00% | +73 | New |
| Ancora Advisors, LLC | 5,000 | $350 | 0.00% | +5,000 | New |
| SkyView Investment Advisors, LLC | 17,500 | $1.00K | 0.00% | +17,500 | New |
| Schonfeld Strategic Advisors LLC | 24,300 | $1.70K | 0.00% | +24,300 | New |
| Walleye Trading LLC | 24,354 | $1.71K | 0.00% | +24,354 | New |
| Whitebox Advisors LLC | 50,000 | $3.50K | 0.00% | +50,000 | New |
| Flow State Investments, L.P. | 55,000 | $3.85K | 0.00% | +55,000 | New |
| Mint Tower Capital Management B.V. | 50,000 | $4.00K | 0.00% | +50,000 | New |
| Mizuho Securities USA LLC | 89,325 | $4.47K | 0.00% | +89,325 | New |
| Yakira Capital Management, Inc. | 76,843 | $5.38K | 0.00% | +76,843 | New |
| Westchester Capital Management, LLC | 92,073 | $6.59K | 0.00% | +92,073 | New |
| Cowen and Company, LLC | 130,287 | $9.12K | 0.00% | +130,287 | New |
| Wolverine Asset Management LLC | 134,917 | $9.44K | 0.00% | +134,917 | New |
| Tenor Capital Management Co., L.P. | 150,000 | $10.5K | 0.00% | +150,000 | New |
| Shaolin Capital Management LLC | 175,000 | $12.2K | 0.00% | +175,000 | New |
| D. E. Shaw & Co., Inc. | 175,352 | $12.6K | 0.00% | +175,352 | New |
| Clear Street LLC | 180,276 | $12.6K | 0.00% | +180,276 | New |
| Walleye Capital LLC | 198,296 | $13.9K | 0.00% | +198,296 | New |
| LMR Partners LLP | 200,000 | $14.0K | 0.00% | +200,000 | New |
| Context Capital Management, LLC | 234,200 | $16.4K | 0.00% | +234,200 | New |
| Clear Street Derivatives LLC | 277,919 | $19.5K | 0.00% | +277,919 | New |
| Aristeia Capital LLC | 272,857 | $19.5K | 0.00% | +272,857 | New |
| Periscope Capital Inc. | 300,000 | $21.0K | 0.01% | +300,000 | New |
| Saba Capital Management, L.P. | 297,847 | $21.3K | 0.00% | +297,847 | New |
| Calamos Advisors LLC | 500,000 | $35.8K | 0.00% | +500,000 | New |
| MMCAP International Inc. SPC | 600,000 | $42.0K | 0.01% | +600,000 | New |
| Polar Asset Management Partners Inc. | 733,000 | $51.3K | 0.00% | +733,000 | New |
| Cantor Fitzgerald, L. P. | 468,500 | $59.9K | 0.01% | +468,500 | New |
| EHP Funds Inc. | 1,232,748 | $86.3K | 0.06% | +1,232,748 | New |
| Anson Funds Management LP | 12,500 | – | – | +12,500 | New |